U.S. markets closed

Aethlon Medical, Inc. (AEMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7100+0.0100 (+0.59%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close1.7000
Open1.6900
Bid1.6500 x 1300
Ask1.8200 x 900
Day's Range1.6750 - 1.7600
52 Week Range1.1900 - 3.7300
Volume71,183
Avg. Volume298,741
Market Cap20.745M
Beta (5Y Monthly)0.51
PE Ratio (TTM)N/A
EPS (TTM)-0.7060
Earnings DateJun 23, 2021 - Jun 28, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences
    PR Newswire

    Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences

    Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that the company will participate in the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10, 2021, and the Maxim Group and M Vest 2021 Emerging Growth Virtual Conference on March 17-18, 2021.

  • AEMD: Company Provides Update on Studies and Business Outlook
    Zacks Small Cap Research

    AEMD: Company Provides Update on Studies and Business Outlook

    By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Aethlon Medical, Inc. (NASDAQ:AEMD) reported 3Q FY2021 results last night and provided an updated outlook on the two clinical studies underway. The company is developing products to diagnose and treat diseases in oncology and viral diseases that are life and organ threatening and not addressed with already approved treatments, is setting

  • ACCESSWIRE

    Aethlon Medical, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 10, 2021 / Aethlon Medical, Inc. (NASDAQ:AEMD) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on February 10, 2021 at 4:30 PM Eastern Time.